Aster DM Healthcare Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Aster DM Healthcare de 49.1% y 11.8% por año respectivamente. Se prevé que el BPA crezca en un 46.7% al año. Se espera que la rentabilidad financiera sea de 15.6% en 3 años.

Información clave

49.1%

Tasa de crecimiento de los beneficios

46.7%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	26.3%
Tasa de crecimiento de los ingresos	11.8%
Rentabilidad financiera futura	15.6%
Cobertura de analistas	Low
Última actualización	10 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 12

Recent updates

With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For

Apr 14

Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate

Mar 27

Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 12

Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly

Feb 07

There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Jan 19

Is Now An Opportune Moment To Examine Aster DM Healthcare Limited (NSE:ASTERDM)?

Apr 03

Is There An Opportunity With Aster DM Healthcare Limited's (NSE:ASTERDM) 29% Undervaluation?

Nov 19

There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Nov 04

Aster DM Healthcare (NSE:ASTERDM) Has A Pretty Healthy Balance Sheet

Aug 30

Is There Now An Opportunity In Aster DM Healthcare Limited (NSE:ASTERDM)?

Aug 17

Is It Too Late To Consider Buying Aster DM Healthcare Limited (NSE:ASTERDM)?

May 04

Return Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Appealing

Mar 28

Should You Review Recent Insider Transactions At Aster DM Healthcare Limited (NSE:ASTERDM)?

Mar 13

Aster DM Healthcare (NSE:ASTERDM) Has A Somewhat Strained Balance Sheet

Feb 26

Aster DM Healthcare's (NSE:ASTERDM) Shareholders Are Down 15% On Their Shares

Feb 11

At ₹156, Is It Time To Put Aster DM Healthcare Limited (NSE:ASTERDM) On Your Watch List?

Jan 27

Has Aster DM Healthcare Limited's (NSE:ASTERDM) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Jan 12

Are Investors Undervaluing Aster DM Healthcare Limited (NSE:ASTERDM) By 30%?

Dec 28

Previsiones de crecimiento de beneficios e ingresos

NSEI:ASTERDM - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2026	175,947	9,598	12,625	N/A	4
3/31/2025	157,724	7,386	9,210	N/A	4
3/31/2024	140,696	3,709	6,588	N/A	5
12/31/2023	135,049	3,241	N/A	N/A	N/A
9/30/2023	129,865	2,843	10,490	19,180	N/A
6/30/2023	124,861	3,613	N/A	N/A	N/A
3/31/2023	119,329	4,249	9,861	18,340	N/A
12/31/2022	113,984	4,804	N/A	N/A	N/A
9/30/2022	108,558	4,894	7,357	14,181	N/A
6/30/2022	105,438	5,501	N/A	N/A	N/A
3/31/2022	102,533	5,260	7,661	13,140	N/A
12/31/2021	99,164	4,051	N/A	N/A	N/A
9/30/2021	94,944	3,492	10,207	15,291	N/A
6/30/2021	92,329	2,751	N/A	N/A	N/A
3/31/2021	86,084	1,477	11,455	15,691	N/A
12/31/2020	85,886	1,735	N/A	N/A	N/A
9/30/2020	86,514	2,202	8,848	12,894	N/A
6/30/2020	84,705	1,904	N/A	N/A	N/A
3/31/2020	86,519	2,766	6,924	12,233	N/A
12/31/2019	86,382	3,548	N/A	N/A	N/A
9/30/2019	84,666	3,161	N/A	N/A	N/A
6/30/2019	82,167	3,240	N/A	N/A	N/A
3/31/2019	79,627	3,331	231	6,009	N/A
12/31/2018	75,460	3,139	N/A	N/A	N/A
9/30/2018	72,102	3,687	N/A	N/A	N/A
6/30/2018	69,394	3,582	N/A	N/A	N/A
3/31/2018	67,212	2,689	177	5,374	N/A
3/31/2017	59,313	1,018	N/A	3,608	N/A
3/31/2016	52,499	-590	N/A	2,027	N/A
3/31/2015	38,758	1,327	N/A	2,355	N/A
3/31/2014	28,711	1,778	N/A	3,272	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (49.1% al año) de ASTERDM es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (49.1% al año) de ASTERDM crezcan más rápidamente que el mercado Indian (18% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de ASTERDM crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (11.8% al año) de ASTERDM crezcan más rápidamente que los del mercado Indian (10.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 11.8% al año) de ASTERDM crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de ASTERDM sea baja dentro de 3 años (15.6%).

Aster DM Healthcare Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 9.3% to ₹459

Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Consensus EPS estimates fall by 16%

Price target increased by 18% to ₹397

Consensus EPS estimates fall by 15%, revenue upgraded

Price target increased by 7.6% to ₹291

Recent updates

Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 23%

Aster DM Healthcare Limited Declares Special Dividend

With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For

Aster DM Healthcare Limited Declares Special Dividend

Investor sentiment improves as stock rises 19%

Aster DM Healthcare Limited Announces Board Changes

Olympus Capital Reportedly Plans Stake Sale in Aster DM Healthcare

Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate

Price target increased by 9.3% to ₹459

Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

New major risk - Financial position

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly

Aster DM Healthcare Limited to Report Q3, 2024 Results on Feb 08, 2024

There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Now 20% undervalued

KKR, Ontario Teachers' Pension Plan and Care Hospitals Reportedly Submit Non-Binding Term Sheets to Acquire Stake in the Indian Business of Aster DM Healthcare

Aster DM Healthcare to Fuel India Expansion Through Buyouts

Now 20% undervalued

New minor risk - Share price stability

Consensus EPS estimates fall by 16%

Price target increased by 18% to ₹397

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: ₹0.62 loss per share (vs ₹0.93 profit in 2Q 2023)

Aster's India Unit Reportedly Draws Suitors Valuing Business At $1.5 Billion

New major risk - Financial position

Aster DM Healthcare Limited Announces Resignation Anoop Moopen as Non-Executive Director

Full year 2023 earnings: EPS misses analyst expectations

Aster DM Healthcare Limited to Report Q1, 2024 Results on Aug 14, 2023

Aster DM Healthcare Limited, Annual General Meeting, Aug 31, 2023

Aster Healthcare's Promoters Reportedly in Talks with Private Equity Groups, Look to Sell India Business

Aster DM Healthcare Confirms Talks with Fajr Capital, Others on Gulf Business

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 15%, revenue upgraded

Price target increased by 7.6% to ₹291

Aster Eye $300 million India Stake Sale

Full year 2023 earnings released: EPS: ₹8.54 (vs ₹10.58 in FY 2022)

Aster DM Healthcare Limited Announces Resignation of Sridar Arvamudhan Iyengar as Non-Executive Independent Director

Aster DM Healthcare Limited to Report Q4, 2023 Results on May 25, 2023

Third quarter 2023 earnings released: EPS: ₹2.80 (vs ₹2.98 in 3Q 2022)

Aster DM Healthcare Limited Appoints Rahul Kadavakolu as Group Chief Marketing Officer

Aster DM Healthcare Limited to Report Q3, 2023 Results on Feb 14, 2023

Aster DM Healthcare Limited Announces Resignation of Sreenath Pocha Reddy as Group Chief Financial Officer, Effective 5 January 2023

Consensus forecasts updated

Price target increased to ₹275

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Aster DM Healthcare Limited Announces Retirement of Prof. Biju Varkkey as Non-Executive Independent Director

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Aster DM Healthcare Limited to Report Q2, 2023 Results on Nov 10, 2022

Aster DM Healthcare Limited (NSEI:ASTERDM) entered into share purchase agreement to acquire 22.69% stake in Sri SaiNatha Multi Speciality Hospitals Pvt. Ltd from promoters and their relatives for INR 250 million.

Investor sentiment improved over the past week

Aster DM Healthcare Limited to Report Q1, 2023 Results on Aug 11, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Aster DM Healthcare Limited, Annual General Meeting, Aug 25, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Aster DM Healthcare Limited to Report Q4, 2022 Results on May 24, 2022

Less than half of directors are independent

Consensus forecasts updated

Is Now An Opportune Moment To Examine Aster DM Healthcare Limited (NSE:ASTERDM)?

Investor sentiment improved over the past week

Is Aster DM Healthcare Limited (NSE:ASTERDM) Trading At A 42% Discount?

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Aster DM Healthcare Limited to Report Q3, 2022 Results on Feb 08, 2022

Should You Investigate Aster DM Healthcare Limited (NSE:ASTERDM) At ₹186?